We looked at the charts of Johnson & Johnson (JNJ) back on Dec. 31, when we wrote, "This is the time and the place to go long JNJ. Risk to $146 for now. The $181 area is our first upside price target." With prices a lot closer to our first price target of $181, another review seems like a good plan.
More from Stocks
It is premature to declare that the worst is over, but the intensity of the selling will go a long way toward helping a bottom to form.
TWLO could bounce in the short-run but avoid the long side for now.
It looks like further declines are possible. Avoid the long side.
This has given investors an opportunity to load up on small speculative names I love over the next 12 to 18 months.